Visual Dysfunction is a Risk Factor of Postoperation Delirium in Parkinson Disease.

World Neurosurg

Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China; Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, China. Electronic address:

Published: June 2023

Objective: To investigate the incidence of and factors influencing postoperative delirium (POD) in Parkinson disease after deep brain stimulation (DBS) surgery.

Methods: A total of 272 patients with Parkinson disease who underwent DBS completed the Visual Impairment in Parkinson Disease Questionnaire (VIPD-Q) and underwent neuro-ophthalmologic examinations including optical coherence tomography and fundus vessel analysis. We retrospect the prevalence of POD in groups with different VIPD-Q scores, retinal nerve fiber layer (RNFL) thicknesses, and vessel percentage areas (VPA). A predictive model based on the VIPD-Q was constructed using multivariate logistic regression and verified using bootstrap validation.

Results: POD was experienced by 65 (23.9%) of 272 patients. Patients with PD who had visual impairment (VIPD-Q > 6) had a higher incidence of POD (chi-square, P < 0.001). The thickness of the RNFL and VPA were also correlated with POD risk. Differences in implantation locations (subthalamic nucleus or pars interna of globus pallidus), operation times, and general anesthesia times did not affect the prevalence of DBS-related POD. A nomogram was constructed based on ophthalmic events to predict the risk of POD.

Conclusions: The study findings provide convincing evidence of the relationship between visual dysfunction and the risk of POD. In view of the higher risk of POD, visually impaired patients with PD should undergo closer monitoring after DBS surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2023.06.048DOI Listing

Publication Analysis

Top Keywords

parkinson disease
16
visual dysfunction
8
dysfunction risk
8
pod
8
272 patients
8
visual impairment
8
risk pod
8
risk
5
visual
4
risk factor
4

Similar Publications

Background: Novel commercial brain-sense neurostimulators enable us to contextualize brain activity with symptom and medication states in real-life ambulatory settings in Parkinson's disease (PD). Although various candidate biomarkers have been proposed for adaptive deep brain stimulation (DBS), a comprehensive comparison of their ambulatory profiles is lacking.

Objectives: To systematically compare the ambulatory neurophysiological dynamics and clinical properties of three candidate biomarkers-low-frequency, beta (β), and finely tuned γ (FTG) activity.

View Article and Find Full Text PDF

Evidence of α-Synuclein/Glucocerebrosidase Dual Targeting by Iminosugar Derivatives.

ACS Chem Neurosci

March 2025

Department of Chemistry "Ugo Schiff" (DICUS), University of Florence, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, FI, Italy.

Intrinsically disordered proteins (IDPs) are highly flexible molecules often linked to the onset of incurable diseases. Despite their great therapeutic potential, IDPs are often considered as undruggable because they lack defined binding pockets, which constitute the basis of drug discovery approaches. However, small molecules that interact with the intrinsically disordered state of α-synuclein, the protein linked to Parkinson's disease (PD), were recently identified and shown to act as chemical chaperones.

View Article and Find Full Text PDF

Background: The gut-brain axis, i.e. the bidirectional communication system between the gut and the brain, has become of central importance in Parkinson disease (PD) research over the past 20 years.

View Article and Find Full Text PDF

The MPTP-animal model of Parkinson's disease has significantly advanced our understanding of Parkinson's disease and the dopaminergic system, helping to establish disease mechanisms and develop therapeutic targets. The non-human primate (NHP) MPTP model is particularly valuable for replicating core Parkinson's disease motor symptoms, anatomical changes and electrophysiological variations seen in humans. However, MPTP-injection protocols often cause substantial suffering, leading to euthanasia.

View Article and Find Full Text PDF

[REM-Sleep-Behavior Disorder - More Than a Simple Parasomnia].

Praxis (Bern 1994)

February 2025

Universitätsklinik für Neurologie, Schlaf-Wach-Epilepsie Zentrum, Inselspital, Universitätsspital, Bern.

Rapid-Eye-Movement (REM) sleep is an essential part of sleep dominating the second half of the night. A disturbance of the phy-siological muscle hypotonia of REM sleep can lead to dream enactment: REM sleep behavior disorder (RBD). In the absence of a disease of the central nervous system or provoking factors such as sleep apnea, alcohol consumption or antidepressants, isolated RBD (iRBD) may be present.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!